AB Science's new Phase 3 trial of masitinib for ALS has been cleared to launch in certain European countries, as well as in ...

Columnist Kristin Neva shares what she feels has worked and not worked in terms of slowing her husband's ALS progression over 15 years.

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

The ongoing EAP that is providing ALS patients with access to MN-166 (ibudilast) outside of a clinical trial is adding more ...

KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

Caregivers can keep communication going for people living with ALS by using tools, patience, and clear language.

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

A noninvasive therapy delivering gentle spinal stimulation was shown to slow disease progression and extend survival in an ...

Guest writer Anita Newton recounts her struggle to access help for her husband's ALS during the height of COVID-19 ...

Columnist Kristin Neva says she's heard that some patients are being told they can't get feeding tubes until they have worsening problems.

The ALS Association has announced the eight winners two new Hoffman award programs designed to improve access to multidisciplinary ALS care.